Skip to Content

innovation

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.

What is CAR T-cell therapy?

Immunotherapy [...]

By uclahealth • October 7, 2019

“My research has been on wearable robotics for rehabilitation or assistance,” muses Gil Hernstadt, an engineer in the new UCLA BioDesign Program. “This is the third or fourth day of the boot camp and this group is great. [...]

By uclahealth • September 5, 2019